Dechra Pharmaceuticals PLC/ GB0009633180 /
9/29/2023 5:29:45 PM | Chg. -1.00 | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
3,797.00GBX | -0.03% | 9,904 Turnover(GBP): 376,271.4000 |
-Bid Size: - | -Ask Size: - | 4.1 bill.GBP | - | - |
Assets
|
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
2020 IFRS in mill. GBP |
2021 IFRS in mill. GBP |
2022 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 45.3000 | 58.4000 | 76.4000 | 87 | 100.3000 | ||||||
Intangible Assets | 709.8000 | 687 | 692.2000 | 715.8000 | 730.5000 | ||||||
Long-Term Investments | 10.5000 | 10.1000 | 17.4000 | 17.1000 | 15.8000 | ||||||
Fixed Assets | - | - | - | - | 848.9000 | ||||||
Inventories | 86.6000 | 104 | 120.8000 | 149.5000 | 175.7000 | ||||||
Accounts Receivable | 81.6000 | 99.9000 | 93.9000 | 106.7000 | 136.8000 | ||||||
Cash and Cash Equivalents | 79.7000 | 80.3000 | 227.4000 | 118.4000 | 120.9000 | ||||||
Current Assets | 247.9000 | 292.1000 | 448.9000 | 392.2000 | 444.4000 | ||||||
Total Assets | 1,017.3000 | 1,048.5000 | 1,237.6000 | 1,214.1000 | 1,293.3000 |
Liabilities
|
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
2020 IFRS in mill. GBP |
2021 IFRS in mill. GBP |
2022 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 136.8000 | ||||||
Long-term debt | - | - | - | - | 325.8000 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 105.5000 | 99.8000 | 90.7000 | 68.9000 | 38 | ||||||
Liabilities | 512.3000 | 539.4000 | 600.1000 | 581.2000 | 626.5000 | ||||||
Share Capital | 1 | 1 | 1.1000 | 1.1000 | - | ||||||
Total Equity | 505 | 509.1000 | 637.5000 | 632.9000 | 666.8000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
Total liabilities equity | 1,017.3000 | 1,048.5000 | 1,237.6000 | 1,214.1000 | 1,293.3000 |
Income Statement
|
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
2020 IFRS in mill. GBP |
2021 IFRS in mill. GBP |
2022 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 407.1000 | 481.8000 | 515.1000 | 608 | 681.8000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 34.1000 | 39 | 52.2000 | 84 | 95.5000 | ||||||
Interest Income | -4.9000 | -10.8000 | -11 | -8.9000 | -16.6000 | ||||||
Income Before Taxes | 28.9000 | 27.8000 | 40.9000 | 74 | - | ||||||
Income Taxes | -7.2000 | -3.1000 | 7 | 18.5000 | 19.4000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
Net Income | 36.1000 | 30.9000 | 33.9000 | 55.5000 | 58.2000 |
Per Share
Cash Flow
|
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
2020 IFRS in mill. GBP |
2021 IFRS in mill. GBP |
2022 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 64 | 81.8000 | 106.4000 | 89.1000 | 122.9000 | ||||||
Cash Flow from Investing Activities | -241.7000 | -61.9000 | -81.5000 | -136.1000 | -78.3000 | ||||||
Cash Flow from Financing | 193.8000 | -20.1000 | 118.9000 | -55.1000 | -46.1000 | ||||||
Decrease / Increase in Cash | 16.1000 | -.2000 | 143.8000 | -102.1000 | - | ||||||
Employees | 1,437 | 1,731 | 1,808 | 1,975 | 2,036 |